NCT02796001View on ClinicalTrials.gov

Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in Humans

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

May 1, 2020

Study Completion Date

May 1, 2020

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

human rhinovirus

human rhinovirus

OTHER

no intervention

4 volunteers were not re-challenged and did not participate in the second challenge

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT02796001 - Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in Humans | Biotech Hunter | Biotech Hunter